Jason Novak

Jason Novak
Jason Novak
Name: Jason Novak
Title: Partner
Company: Haynes and Boone


Jason is a Partner in Haynes and Boone, supporting the launch and growth of the firm’s Digital Health and Precision Medicine Practice Group. Jason focuses on advising entities, both large and small, on the various legal issues that can arise with emerging technologies in the healthcare and life sciences industries. Tech and Biotech are traditionally disparate technologies that, when blended together to form many of our most exciting new technologies, bring forth a combination of unique and interrelated legal issues. As such, Jason’s practice focus is two-fold: (a) serve the IP needs of the biotech industry, particularly instrumentation and software (computational biology, precision medicine, bioinfomatics), and (b) provide a true “in-house” IP perspective and understanding to clients in all industries.

Areas of Patent experience: Biotech (with emphasis in life sciences tooling), analytical instrumentation, and software (with emphasis in computational biology/precision medicine/bioinformatics/companion diagnostics). Also experience in chemical, mechanical, medical device, food and electrochemical industries

After graduating from Illinois Institute of Technology in 2000, Jason became an engineer at Kraft Foods R&D. Responsibilities included leading numerous product and process redesigns, requiring knowledge in flavor and emulsion chemistry, chemical and food process engineering. Jason also participated in cross-functional strategic planning, requiring knowledge of commercialization processes, capital approval and installation, product development and quality approval.

After graduating Chicago-Kent College of Law in 2006, Jason joined Bell Boyd & Lloyd, which later became K&L Gates. There, Jason drafted/prosecuted numerous patent applications for various technologies. Jason also landscaped various technologies, rendered numerous opinions regarding patentability, clearance and invalidity, and participated in oppositions, ex parte reexams, and reissues.

From 2011 to mid-2016, Jason became an IP Counsel at Life Technologies (later acquired by Thermo Fisher), later becoming a Director at Thermo Fisher, responsible for managing IP needs for all Genetic Sciences instruments and associated software platforms, including thermal cycler systems, dPCR systems and Capillary Electrophoresis instruments.